Equities

Unihealth Consultancy Ltd

UNIHEALTH:NSI

Unihealth Consultancy Ltd

Actions
  • Price (INR)146.95
  • Today's Change-0.90 / -0.61%
  • Shares traded2.00k
  • 1 Year change+4.74%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 05:33 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Unihealth Consultancy Limited is an India-based company, which provides complete health solutions across India and multiple geographies in Africa. Under its flagship UMC Hospitals brand, the Company operates a cumulative bed-strength of approximately 200 tertiary care beds across its facilities in Uganda, Nigeria, and Tanzania. The Company is also providing consultancy services for projects, under varying operational stages, with a bed-strength approximately 1,000 beds in India and multiple African countries. Its businesses include Hospitals & Medical Centers, Healthcare Consultancy, Distribution & Trade, and Medical Value Travel. It is a distributor for medical consumables, pharmaceuticals, nutraceuticals, and medical equipment manufactured by Indian manufacturers. It has specialized medical centers in Tanzania. It also exports wide range of general medical consumables and medical equipment from India to various countries in Africa.

  • Revenue in INR (TTM)504.72m
  • Net income in INR112.91m
  • Incorporated2010
  • Employees17.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Aatmaj Healthcare Ltd157.38m8.81m554.83m155.0063.54--32.853.530.38640.38646.97--------1,015,361.00--------84.34--5.60----7.12-----42.06---85.09------
Sangani Hospitals Ltd156.76m26.97m995.39m69.0032.172.9733.386.352.252.2512.6124.310.57018.146.802,271,913.009.81--10.37--64.77--17.20--14.56--0.0025--0.053--81.76------
Lotus Eye Hospital and Institute Ltd485.33m21.54m1.33bn336.0061.34--21.412.741.041.0423.44--------1,444,446.00--4.15--4.5852.1953.244.446.09--12.77----2.484.64-28.5232.713.79--
Maitreya Medicare Ltd477.63m31.71m2.23bn--70.207.3650.104.664.684.6870.4944.63----------------80.53--6.64--2.9212.570.1582--21.29---24.97------
Unihealth Consultancy Ltd504.72m112.91m2.23bn17.0016.692.4216.474.418.678.6737.5159.73------29,689,120.00--------82.05--22.31--5.165.880.1008--10.95--34.20------
Nephro Care India Ltd-100.00bn-100.00bn3.58bn127.00--6.76----------32.11------------------------0.5994--0.00--59.31--85.94------
Data as of Nov 22 2024. Currency figures normalised to Unihealth Consultancy Ltd's reporting currency: Indian Rupee INR
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.